While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders. This evolution signals a potential inflection point, where MCR-targeted drugs could move from orphan exclusivity toward...
MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight
Seeking Alpha / 13 hours ago 3 Views
Comments